Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-09

Clinical Trial Update: Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tofacitinib vs methotrexate for maintained treatment of granulomatosis with polyangiitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Granulomatosis With Polyangiitis | Phase 4 | Status: UNKNOWN